EN|CN

   

Home » Education » 

Sub-forum 2:Quality Improvement and System Standard Construction

Sub-forum 2:Quality Improvement and System Standard Construction

MDiT Forum and Regulation Summit 2024—— Sub-forum 2:Quality Improvement and System Standard Construction

Co-organizers: Medtec China

Introduction

Conference Background:

Quality is paramount when it comes to healthcare, and ensuring the quality and safety of medical devices has always been a top priority for businesses.

In recent years, the domestic market has faced significant competition, leading more and more enterprises to expand their operations overseas. Due to the advantages of better exploring international markets, reducing costs, and enhancing global competitiveness, many businesses have opted to establish overseas factories. However, different countries have varying regulations and legal requirements, as well as differences in quality standards for medical devices. Therefore, enterprises should conduct comprehensive planning and strategic considerations when making early-stage decisions about establishing factories.

Regardless of whether a factory is built overseas or in the United States, it cannot escape the influence of natural disasters, political and economic factors, and other relevant external forces. In addition to external factors, internal issues within suppliers, such as the frequent recalls of faulty medical devices in early 2024, can lead to supply chain disruptions. This has prompted companies to consider strategies for enhancing supply chain resilience. Even when such events are avoided, a company’s supply operations cannot continue smoothly on their own. It is crucial to enhance the enterprise’s ability to tolerate risks and build resilience in order to mitigate and minimize the impact of supply chain disruptions.

With the rapid advancement of artificial intelligence, production methods have progressed from the early stages of automation 1.0 to the current era of 3.0. There is a growing trend among companies to seek ways to cut costs and enhance efficiency and sustainability. Simultaneously, ensuring the quality of products, especially the safety and efficacy of medical devices, remains a top priority. How can companies manage effectively from the production end to improve competitiveness and achieve desired goals?

This summit has invited experts from various sectors to discuss and analyze the current hot topics in the industry, providing the latest information on standards related to medical device regulation and quality management. Additionally, they aim to develop effective implementation strategies for the attendees.

Who Should Attend:

  • Medical device manufacturers: heads of departments of manufacturing, technology, quality R&D, as well as project/company leaders.
  • The enterprises engaged in medical device regulatory and quality consulting, research and services.
  • Medical device quality regulatory agencies and others

Agenda

September 24, 2024, PM | Hotel Conference Room

Time

Agenda

13:20-13:30

Moderator Remarks

13:30-14:10

Overseas Manufacturing Plant Project Planning and Strategic Implications for Medical Device Firms

14:10-14:50

Supply Chain Toughness and Availability of High-end Medical Devices / Flexible Manufacturing

14:50-15:20

Tea Break

15:20-16:00

Surgical Robot Production Methods Based on Lean Concepts

16:00-16:40

IVD Self-powered Pipetting Solution / Molecular Diagnostic Reagent Core Raw Material Quality Control and Process Improvement

16:40-16:50

Conference Close

*The agenda may be subject to changes due to adjustment of confirmed speakers

Speaker

Sponsor/Package 

Registration 

Transportation 

Speech & Cooperation

Rebecca Lv

T: +86-21 6157 7279

E:Rebecca.lv@informa.com

Sponsor & Paid Conference

Lorelei Yu

+86-21-61573861

E:Lorelei.Yu@informa.com

Media & Free Conference

Carina Li

T:+86 10 6562 3307

E:Carina.li@informa.com

MDiT Forum and Regulation Summit 2024—— Sub-forum 2:Quality Improvement and System Standard Construction

Co-organizers:Medtec China

Conference Background:

Quality is paramount when it comes to healthcare, and ensuring the quality and safety of medical devices has always been a top priority for businesses.

In recent years, the domestic market has faced significant competition, leading more and more enterprises to expand their operations overseas. Due to the advantages of better exploring international markets, reducing costs, and enhancing global competitiveness, many businesses have opted to establish overseas factories. However, different countries have varying regulations and legal requirements, as well as differences in quality standards for medical devices. Therefore, enterprises should conduct comprehensive planning and strategic considerations when making early-stage decisions about establishing factories.

Regardless of whether a factory is built overseas or in the United States, it cannot escape the influence of natural disasters, political and economic factors, and other relevant external forces. In addition to external factors, internal issues within suppliers, such as the frequent recalls of faulty medical devices in early 2024, can lead to supply chain disruptions. This has prompted companies to consider strategies for enhancing supply chain resilience. Even when such events are avoided, a company’s supply operations cannot continue smoothly on their own. It is crucial to enhance the enterprise’s ability to tolerate risks and build resilience in order to mitigate and minimize the impact of supply chain disruptions.

With the rapid advancement of artificial intelligence, production methods have progressed from the early stages of automation 1.0 to the current era of 3.0. There is a growing trend among companies to seek ways to cut costs and enhance efficiency and sustainability. Simultaneously, ensuring the quality of products, especially the safety and efficacy of medical devices, remains a top priority. How can companies manage effectively from the production end to improve competitiveness and achieve desired goals?

This summit has invited experts from various sectors to discuss and analyze the current hot topics in the industry, providing the latest information on standards related to medical device regulation and quality management. Additionally, they aim to develop effective implementation strategies for the attendees.

Who Should Attend?
  • Medical device manufacturers: heads of departments of manufacturing, technology, quality R&D, as well as project/company leaders.
  • The enterprises engaged in medical device regulatory and quality consulting, research and services.
  • Medical device quality regulatory agencies and others

Agenda

September 24, 2024, PM | Hotel Conference Room

Time

Agenda

13:20-13:30

Moderator Remarks

13:30-14:10

Overseas Manufacturing Plant Project Planning and Strategic Implications for Medical Device Firms

14:10-14:50

Supply Chain Toughness and Availability of High-end Medical Devices / Flexible Manufacturing

14:50-15:20

Tea Break

15:20-16:00

Surgical Robot Production Methods Based on Lean Concepts

16:00-16:40

IVD Self-powered Pipetting Solution / Molecular Diagnostic Reagent Core Raw Material Quality Control and Process Improvement

16:40-16:50

Conference Close

*The agenda may be subject to changes due to adjustment of confirmed speakers

Speaker

Sponsor/Package

Registration

Travel Service

Speech & Cooperation

Rebecca Lv

T: +86-21 6157 7279

E:Rebecca.lv@informa.com

Sponsor & Paid Conference

Lorelei Yu

+86-21-61573861

E:Lorelei.Yu@informa.com

Media & Free Conference

Carina Li

T:+86 10 6562 3307

E:Carina.li@informa.com